Can better sleep help people with chronic pain use fewer opioids?

NCT ID NCT06345872

Recruiting now Symptom relief Sponsor: University of South Florida Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two behavioral programs for people with chronic pain, chronic insomnia, and long-term opioid use. One program uses cognitive behavioral therapy for insomnia (CBT-I), the other is standard treatment. The goal is to see if improving sleep can also reduce opioid use. 165 adults are being recruited, and the study is currently enrolling.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CBT-I (cognitive behavioral therapy for insomnia) and treatment as usual
What this could lead to: If successful, this could provide a non-drug way to improve sleep and help people with chronic pain reduce their opioid use.
What could go wrong: This is a behavioral intervention study, not a drug trial. Results depend on participant adherence, and benefits may vary. It is still recruiting and not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome fibromyalgia insomnia opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC INSOMNIA CHRONIC PAIN OPIOID USE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of South Florida
RECRUITING

Tampa, Florida, 33612, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.